US Bancorp DE reduced its position in shares of CVS Health Co. (NYSE:CVS - Free Report) by 29.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 317,604 shares of the pharmacy operator's stock after selling 133,502 shares during the quarter. US Bancorp DE's holdings in CVS Health were worth $19,971,000 as of its most recent SEC filing.
A number of other large investors also recently bought and sold shares of CVS. Norden Group LLC lifted its position in shares of CVS Health by 10.7% during the 1st quarter. Norden Group LLC now owns 6,830 shares of the pharmacy operator's stock valued at $545,000 after buying an additional 660 shares in the last quarter. Mission Wealth Management LP grew its position in shares of CVS Health by 70.9% in the first quarter. Mission Wealth Management LP now owns 11,321 shares of the pharmacy operator's stock valued at $903,000 after purchasing an additional 4,696 shares during the period. Prosperity Consulting Group LLC increased its stake in shares of CVS Health by 17.3% during the first quarter. Prosperity Consulting Group LLC now owns 4,331 shares of the pharmacy operator's stock worth $345,000 after purchasing an additional 638 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. raised its position in shares of CVS Health by 3.6% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 344,490 shares of the pharmacy operator's stock worth $26,047,000 after purchasing an additional 11,904 shares during the last quarter. Finally, PDS Planning Inc lifted its stake in CVS Health by 12.4% in the 1st quarter. PDS Planning Inc now owns 3,984 shares of the pharmacy operator's stock valued at $318,000 after buying an additional 441 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company's stock.
A number of equities analysts have commented on CVS shares. Wells Fargo & Company increased their target price on CVS Health from $60.00 to $61.00 and gave the company an "equal weight" rating in a report on Monday, August 12th. Deutsche Bank Aktiengesellschaft decreased their price objective on CVS Health from $64.00 to $63.00 and set a "hold" rating on the stock in a report on Friday, August 9th. Cantor Fitzgerald reiterated a "neutral" rating and issued a $62.00 target price on shares of CVS Health in a research report on Tuesday, October 1st. TD Cowen upgraded shares of CVS Health from a "hold" rating to a "buy" rating and boosted their price target for the stock from $59.00 to $85.00 in a research report on Friday, October 4th. Finally, Evercore ISI increased their price objective on shares of CVS Health from $62.00 to $75.00 and gave the company an "outperform" rating in a report on Tuesday, October 8th. Nine research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to data from MarketBeat.com, CVS Health has a consensus rating of "Moderate Buy" and a consensus price target of $74.58.
Get Our Latest Analysis on CVS Health
NYSE CVS opened at $55.81 on Friday. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.86 and a quick ratio of 0.66. The stock has a market capitalization of $70.21 billion, a P/E ratio of 9.93, a PEG ratio of 0.83 and a beta of 0.54. The firm's 50-day moving average is $59.66 and its two-hundred day moving average is $59.62. CVS Health Co. has a 12 month low of $52.77 and a 12 month high of $83.25.
CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share for the quarter, topping analysts' consensus estimates of $1.73 by $0.10. The firm had revenue of $91.23 billion during the quarter, compared to analysts' expectations of $91.41 billion. CVS Health had a net margin of 1.98% and a return on equity of 12.72%. The firm's quarterly revenue was up 2.6% on a year-over-year basis. During the same quarter last year, the company posted $2.21 EPS. On average, sell-side analysts anticipate that CVS Health Co. will post 6.41 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were given a dividend of $0.665 per share. The ex-dividend date was Monday, October 21st. This represents a $2.66 annualized dividend and a dividend yield of 4.77%. CVS Health's dividend payout ratio is presently 47.33%.
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CVS Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.
While CVS Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.